2025-06283Notice

Merck Expands NJ Pharma Lab with Foreign-Trade Zone Perks

Published Date: 4/14/2025

Notice

Summary

Merck, Sharp & Dohme LLC wants to expand their Rahway, New Jersey facility to make new pharmaceutical products for diseases like cancer and infections using special foreign materials. This change lets them save on import duties and speed up research. Public comments are open until May 27, 2025, so folks can share their thoughts before the plan moves forward.

No Economic Impacts Identified for this Document

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
4/14/2025

Department and Agencies

Department
Independent Agency
Agency
Commerce Department
Foreign-Trade Zones Board
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register